SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-24-041123
Filing Date
2024-03-29
Accepted
2024-03-29 15:36:27
Documents
6
Period of Report
2024-03-29

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm249672d1_6k.htm 6-K 18529
2 EXHIBIT 1.1 tm249672d1_ex1-1.htm EX-1.1 318067
3 EXHIBIT 5.1 tm249672d1_ex5-1.htm EX-5.1 51134
4 EXHIBIT 8.2 tm249672d1_ex8-2.htm EX-8.2 19447
5 GRAPHIC tm249672d1_ex8-2img001.jpg GRAPHIC 7477
6 GRAPHIC tm249672d1_ex5-1img001.jpg GRAPHIC 8596
  Complete submission text file 0001104659-24-041123.txt   430777
Mailing Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000
Business Address 4F, BUILDING C14, NO. 218, XINGHU STREET SUZHOU INDUSTRIAL PARK JIANGSU F4 00000 86-512-87773632
Adagene Inc. (Filer) CIK: 0001818838 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39997 | Film No.: 24803967
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)